Identification of Candidate Tolerogenic CD8⁺ T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model

Figure 3

Median age to develop elevated blood glucose after various tolerizing therapies. Data shown in Figures 2(c) and 2(d) were analyzed using the Gehan-Breslow-Wilcoxon test for median age (week) to develop disease. All values are compared within an experiment to the control group and are shown above each bar. The number of mice in each experiment is described in the legend of Figure 2.